Ruth Lopert, MD

Ruth Lopert, MD a 2006-07 Commonwealth Fund Harkness Fellow in Health Care Policy and is working with Bruce Stuart, Executive Director of the Lamy Center as well as Marilyn Moon of the American Institutes for Research on her project entitled, “Comparing Cost, Coverage and Access to Pharmaceuticals under Australian and U.S. Policy Frameworks. 

 Dr. Lopert is a public health physician and pharmacoepidemiologist, and is currently principal advisor in the Pharmaceutical Policy Taskforce in the Commonwealth Department of Health and Ageing in Canberra, Australia.  She is a member of the WHO Expert Advisory Panel on Drug Policies and Management, and was a negotiator of the pharmaceutical provisions of the Australia United States Free Trade Agreement.  Dr. Lopert has published and presented internationally in pharmacoeconomics and has particular interests in pharmaceutical policy, pharmaceutical intellectual property issues, drug pricing and access to medicines.

Dr. Lopert can be reached at 410-706-1489 or emailed at rlopert@rx.umaryland.edu.